TrialHuman vaccines & immunotherapeutics2026

Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China.

Xuanwen Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.